Traders in Celator Attributing Plunge Lower to Update on ClinicalTrials.gov Showing Study Suspended for 'CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome'
Get News First. Profit Faster
With Benzinga Professional get unlimited access to ALL content! PLUS:
- REALTIME NEWSFEED
- REALTIME AUDIO NEWS
- FULL CALENDAR SUITE
- CHAT WITH OUR NEWS DESK
RECENT PRO ALERTS
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.